Authors:
Frosch, D
Porzsolt, F
Heicappell, R
Kleinschmidt, K
Schatz, M
Weinknecht, S
Kaplan, RM
Citation: D. Frosch et al., Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease, QUAL LIFE R, 10(2), 2001, pp. 165-173
Authors:
Souchon, R
Krege, S
Schmoll, HJ
Albers, P
Beyer, J
Bokemeyer, C
Classen, J
Dieckmann, KP
Hartmann, M
Heidenreich, A
Holtl, W
Kliesch, S
Kohrmann, KU
Kuczyk, M
Schmidberger, H
Weinknecht, S
Winter, E
Wittekind, C
Bamberg, M
Citation: R. Souchon et al., Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors. Results of an update conference based on evidence-based medicine (EBM), STRAH ONKOL, 176(9), 2000, pp. 388-405
Authors:
von der Maase, H
Andersen, L
Crino, L
Weinknecht, S
Dogliotti, L
Citation: H. Von Der Maase et al., Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial, ANN ONCOL, 10(12), 1999, pp. 1461-1465
Authors:
Bamberg, M
Schmidberger, H
Meisner, C
Classen, J
Souchon, R
Weinknecht, S
Schorcht, J
Walter, F
Engenhart-Cabillic, R
Schulz, U
Born, H
Flink, M
Citation: M. Bamberg et al., Radiotherapy for stages I and IIA/B testicular seminoma, INT J CANC, 83(6), 1999, pp. 823-827
Authors:
Albers, P
Siener, R
Hartmann, M
Weinknecht, S
Schulze, H
Rebmann, U
Kuczyk, M
deRiese, W
Loy, V
Bierhoff, E
Wittekind, C
Citation: P. Albers et al., Risk factors for relapse in stage I non-seminomatous germ-cell tumors: Preliminary results of the German Multicenter Trial, INT J CANC, 83(6), 1999, pp. 828-830
Citation: S. Weinknecht et al., Marker-positive patients with germ-cell tumors: when is residual tumor resection useful?, UROLOGE, 37(6), 1998, pp. 621-624